SNWV
SANUWAVE Health, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$4.38
−1.57%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 43.9M | 44.1M | 32.6M | 20.4M | 16.7M |
| Cost of Revenue | 10.9M | 10.1M | 8.1M | 6.0M | 4.3M |
| Gross Profit | 33.0M | 34.0M | 24.6M | 14.4M | 12.4M |
| Operating Expenses | |||||
| R&D Expense | 2.2M | 1.4M | 673.0K | 579.0K | 567.0K |
| SG&A Expense | 29.6M | 26.8M | 17.7M | 13.6M | 20.0M |
| General & Admin Expense | 21.0M | 19.4M | 11.3M | 8.7M | 12.6M |
| Selling & Marketing Expense | 8.5M | 7.4M | 6.3M | 4.9M | 7.5M |
| Other Expenses | 543.0K | 880.0K | 789.0K | 752.0K | 766.0K |
| Total Operating Expenses | 32.3M | 29.0M | 19.1M | 14.9M | 21.4M |
| Cost and Expenses | 43.2M | 39.1M | 27.2M | 20.9M | 25.7M |
| Operating Income (EBIT) | 678.0K | 4.9M | 5.4M | (540.0K) | (9.0M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 3.6M | 6.2M | 13.6M | 15.6M | 14.1M |
| Net Interest Income | (3.6M) | (6.2M) | (13.6M) | (15.6M) | (14.1M) |
| Other Non-Op Income/Expense | 13.7M | 7.0M | (36.8M) | (25.3M) | (1.3M) |
| Non-Operating Income (excl Interest) | (17.3M) | (13.2M) | 23.1M | 9.6M | (12.8M) |
| EBT (Pre-Tax Income) | 14.4M | 11.9M | (31.3M) | (25.8M) | (10.3M) |
| Income Tax Expense | 92.0K | 86.0K | 27.0K | 4.0K | 2.0K |
| Bottom Line | |||||
| Net Income | 14.3M | 11.8M | (31.4M) | (25.8M) | (10.3M) |
| Earnings from Cont. Ops | 14.3M | 11.8M | (31.4M) | (25.8M) | (10.3M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 14.3M | 3.7M | (31.4M) | (25.8M) | (10.3M) |
| Per Share | |||||
| Basic EPS | $1.67 | $1.38 | ($7.03) | ($12.19) | ($7.02) |
| Diluted EPS | $0.90 | $0.41 | ($7.03) | ($12.19) | ($7.02) |
| Revenue Per Share | $5.10 | $5.14 | $7.31 | $9.64 | $11.43 |
| Shares | |||||
| Basic Shares Outstanding | 8.6M | 8.6M | 4.5M | 2.1M | 1.5M |
| Diluted Shares Outstanding | 8.6M | 9.1M | 4.5M | 2.1M | 1.5M |
| Profitability Metrics | |||||
| EBITDA | 19.3M | 19.4M | (16.6M) | (9.2M) | 4.8M |
| D&A | 1.3M | 1.3M | 1.1M | 1.0M | 952.0K |
| EBIT | 18.0M | 18.1M | (17.7M) | (10.2M) | 3.8M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026